HHS’s Proposed Rebate Rule Could Transform Pharma Industry
February 1, 2019
HHS finally released a long-awaited proposed rule that, if implemented, stands to have a wide-reaching impact on the pharmaceutical industry. The proposal targets drug rebates provided by pharmaceutical manufacturers to plan sponsors under Medicare Part D and Medicaid MCOs and to PBMs contracting with them. The approach would pose an array of logistical challenges to multiple stakeholders but also would shed some light on a practice that has been in the crosshairs recently.